J A Kemp Webinar: Patenting Antibodies at the EPO

17 May 2018

Antibody therapeutics is a rapidly developing field, with many antibody-based therapies now on the market and in the clinic. Patenting of antibodies, particularly for known targets, is proving increasingly difficult. The day-to day practice at the European Patent Office is constantly evolving, moving forward much faster than the Case Law. This webinar makes use of the significant experience of J A Kemp’s attorneys in prosecuting antibody cases at the European Patent Office, as well as discussions with EPO examiners, highlighting recent trends in examination and strategies for addressing objections.

Topics include:

  • When broad antibody claims can be obtained
  • How to approach inventive step when the target is known
  • What data to provide to support inventive step
  • Functional/epitope claims
  • Other routes to patentability

This is a technical webinar aimed at:

  • In-house IP practitioners working in the life sciences area
  • Attorneys involved in drafting, prosecuting and advising on antibody claims
  • People involved in developing antibody products in new and growing businesses or academic institutions


This webinar is now available on demand


To book please visit the registration page.

Can We Help You?